Leadership & Pay ·
Adaptive Biotechnologies Corporation held its annual meeting of shareholders on June 5, 2026, where shareholders voted…
ADPTAdaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation held its annual meeting of shareholders on June 5, 2026, where shareholders voted to elect Robert Hershberg, PhD, MD and Katey Owen, PhD to the Board of Directors, approved the advisory compensation for 2025 named executive officers, and ratified Ernst & Young LLP as the independent registered public accounting firm for 2026. Adaptive Biotechnologies Corporation is an immunology-focused biotechnology company.